A new chapter on the Biologic Basis of Molecular Targeted Therapy, as well as a state-of-the-art review of the current development and use of novel immunotherapeutics, bring you up to date with the rationale and use of these newer agents in cancer treatment. Completely updated throughout to reflect current best practices, including primary indications, usual dosage and schedule, special precautions and expected toxicities for dozens of new drugs and biologic agents. New contributors provide a fresh perspective on timely topics in cancer treatment and care. An updated section on supportive care reflects this essential aspect of the oncology team’s focus

search tags: Samir N. Khleif, Olivier Rixe, Roland T. Skeel